Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lemaitre Vascular (LMAT) Change in Cash (2016 - 2025)

Lemaitre Vascular (LMAT) has disclosed Change in Cash for 16 consecutive years, with $2.8 million as the latest value for Q4 2025.

  • On a quarterly basis, Change in Cash fell 40.33% to $2.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $2.6 million, a 96.42% increase, with the full-year FY2025 number at $2.6 million, up 96.42% from a year prior.
  • Change in Cash was $2.8 million for Q4 2025 at Lemaitre Vascular, up from -$1.7 million in the prior quarter.
  • In the past five years, Change in Cash ranged from a high of $6.2 million in Q4 2023 to a low of -$4.3 million in Q2 2024.
  • A 5-year average of $74000.0 and a median of -$768500.0 in 2024 define the central range for Change in Cash.
  • Peak YoY movement for Change in Cash: crashed 284.68% in 2021, then surged 363.51% in 2022.
  • Lemaitre Vascular's Change in Cash stood at -$3.5 million in 2021, then skyrocketed by 163.2% to $2.2 million in 2022, then soared by 179.96% to $6.2 million in 2023, then dropped by 25.88% to $4.6 million in 2024, then tumbled by 40.33% to $2.8 million in 2025.
  • Per Business Quant, the three most recent readings for LMAT's Change in Cash are $2.8 million (Q4 2025), -$1.7 million (Q3 2025), and $1.8 million (Q2 2025).